Thursday , November 28 2024
Home / Lars P. Syll / Le vaccin d’AstraZeneca et la balance bénéfice-risque

Le vaccin d’AstraZeneca et la balance bénéfice-risque

Summary:
Le vaccin d’AstraZeneca et la balance bénéfice-risque .[embedded content]

Topics:
Lars Pålsson Syll considers the following as important:

This could be interesting, too:

Lars Pålsson Syll writes Riksbankens oansvariga penningpolitik

Lars Pålsson Syll writes Tillsätt en krisgrupp för järnvägen

Lars Pålsson Syll writes The victims of honour culture

Lars Pålsson Syll writes Ekonomisk politik och finanspolitiska ramverk

Le vaccin d’AstraZeneca et la balance bénéfice-risque

.

Lars Pålsson Syll
Professor at Malmö University. Primary research interest - the philosophy, history and methodology of economics.

Leave a Reply

Your email address will not be published. Required fields are marked *